Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity
published in: Cancer Immunology Research
date of publication: 2013-11-11
Cites articles 59
- 2011-06-23
Date
Title
Article - wd:Q39143599